This letter lays out the Minister's expectations of the Gene Technology Regulator.
These documents support the Risk Assessment and Risk Management Plans (RARMPs) prepared for applications for dealings involving intentional release (DIRs) of GMOs into the environment. They address matters common to many DIR risk assessments and are referred to in relevant RARMPs.
Gene Technology (Equine Influenza Vaccine) Emergency Dealing Extension Determination 2008
This impact statement assesses the changes recommended by the 2016-19 Technical Review of the Gene Technology Regulations.
This application form must be used for applications for a licence for dealings (activities) NOT involving the intentional release of a GMO into the environment (DNIR).
The Gene Technology Regulator may invoke these guidelines when determining licence and certification conditions.
Use this form to apply for a declaration that specified information is confidential commercial information (CCI) under the Gene Technology Act 2000.
IBCs can use this model form when making an NLRD record of assessment (RoA) and recording that it has been given to the proponent.
This application form is for dealings (activities) involving limited and controlled release of genetically modified (GM) plants into the environment.
This is a hypothetical case study provided as an example. It should not be cited as evidence in an application. Although the data and discussions are representative, this example may not include all considerations needed when assessing risks from a proposed GM plant commercial release.